Hantavirus in depth.

Overview

Hantavirus is a genus of single-stranded, negative-sense RNA viruses belonging to the family Hantaviridae (order Bunyavirales). Unlike most bunyaviruses, hantaviruses are not transmitted by arthropod vectors but are carried by rodents — each hantavirus strain is associated with a specific rodent reservoir. Humans are infected incidentally when they come into contact with infected rodent excreta (urine, feces, saliva), primarily through inhalation of aerosolized viral particles.

Hantaviruses cause two clinically distinct syndromes depending on the viral strain and geographic region. In the Americas, infection with New World hantaviruses (particularly Sin Nombre virus) causes Hantavirus Pulmonary Syndrome (HPS) — a severe and often fatal respiratory illness with a case fatality rate of 35–38%. In Asia and Europe, Old World hantaviruses (Hantaan, Seoul, Puumala, Dobrava) cause Hemorrhagic Fever with Renal Syndrome (HFRS), primarily affecting the kidneys, with mortality ranging from less than 1% (Puumala) to 15% (Hantaan) depending on the strain.

The WHO estimates approximately 200,000 cases of HFRS occur globally each year, with the majority in China, which accounts for roughly 70–90% of global HFRS cases. HPS is less common but far more lethal: the United States CDC has recorded approximately 850 confirmed HPS cases since the disease was first identified in 1993, with a case fatality rate consistently around 35–38%. Argentina and Chile together account for most South American HPS cases, with the Andes virus causing the majority of cases there — notably the only hantavirus documented to spread person-to-person.

History & Origin

Hantavirus disease was first recognized during the Korean War (1950–1953), when thousands of United Nations soldiers developed an acute febrile illness with renal failure and hemorrhagic manifestations — now recognized as HFRS caused by Hantaan virus. The causative agent, Hantaan virus, was isolated by Ho Wang Lee and colleagues in 1976 from the striped field mouse (Apodemus agrarius) near the Hantan River in South Korea, lending the virus family its name.

Hantavirus Pulmonary Syndrome was not recognized until May 1993, when a cluster of previously healthy young adults in the Four Corners region of the southwestern United States (New Mexico, Arizona, Colorado, Utah) developed a rapid-onset, severe respiratory illness. Initial investigations by CDC and the New Mexico Department of Health identified a novel hantavirus — subsequently named Sin Nombre virus ("virus with no name") — carried by the deer mouse (Peromyscus maniculatus). The 1993 outbreak killed 13 of 24 confirmed cases, drawing intense international attention.

The discovery that hantaviruses were circulating in the Americas — and causing a different clinical syndrome from the Asian HFRS — prompted a major expansion of hantavirus surveillance worldwide. More than 40 hantavirus species are now recognized, distributed across every inhabited continent except Australia, each associated with specific rodent hosts.

Transmission

Hantavirus transmission from rodents to humans occurs via three principal routes, all involving contact with infected rodent excreta:

• Inhalation (primary route): Breathing in aerosols of dried, infected rodent urine, feces, or saliva — the most common route of infection. This occurs when sweeping, vacuuming, or disturbing rodent-contaminated areas without respiratory protection.
• Direct contact: Touching rodent droppings, nesting materials, or infected rodents and then touching the mouth, eyes, or nose.
• Rodent bites: Rare but documented route of transmission.
• Person-to-person transmission: Does not occur with most hantaviruses. The exception is Andes virus (South America), which can spread between close contacts — making it the only hantavirus with documented person-to-person transmission.

High-risk activities include opening a cabin or shed that has been closed for months, cleaning areas with rodent infestations, farming in endemic areas, and camping or hiking in areas with high rodent populations. Activities that disturb soil or dust (plowing, construction) in endemic areas also carry elevated risk.

Symptom Timeline

The incubation period ranges from 1–8 weeks (typically 2–4 weeks). Clinical presentation differs markedly between HPS and HFRS.

Diagnosis

• IgM/IgG serology (ELISA): Detection of hantavirus-specific IgM antibodies is the most common diagnostic method. IgM is present at or shortly after symptom onset in most patients. IgG indicates prior infection.
• RT-PCR: Detection of hantavirus RNA in blood — most sensitive in the early febrile phase before antibody production. Used to confirm and identify the specific hantavirus strain.
• Immunohistochemistry: Detection of hantavirus antigen in tissue samples — particularly useful in fatal cases where serology was not obtained antemortem.
• Chest X-ray / CT scan: In HPS, bilateral interstitial infiltrates (pulmonary edema pattern) appear rapidly in the cardiopulmonary phase — "bat wing" or diffuse ground-glass opacities.
• Complete Blood Count: Thrombocytopenia, elevated hematocrit, and presence of immunoblasts (large atypical lymphocytes) in peripheral blood are characteristic of HPS. A rising hematocrit plus thrombocytopenia plus respiratory symptoms in a patient from an endemic area should prompt immediate hantavirus testing.
• Metabolic panel / urinalysis: In HFRS: elevated creatinine, proteinuria, hematuria indicate renal involvement.

Treatment

No specific WHO- or FDA-approved antiviral therapy exists for hantavirus infection. Management is supportive and depends on the syndrome.

HPS Treatment (ICU)

• Intensive monitoring: Patients with confirmed or suspected HPS should be admitted to an ICU immediately, given the potential for rapid deterioration within hours.
• Supplemental oxygen / mechanical ventilation: Oxygen supplementation for hypoxia; mechanical ventilation for respiratory failure.
• ECMO (Extracorporeal Membrane Oxygenation): Has been used successfully in severe HPS cases refractory to conventional ventilation. Some case series suggest survival benefit.
• Conservative fluid management: Critical — aggressive IV fluid resuscitation worsens pulmonary edema. Vasopressors (dopamine, norepinephrine) preferred for maintaining blood pressure over large fluid volumes.
• Intravenous Ribavirin: Has been studied for HPS but controlled trials have not demonstrated clear benefit. Used in some HFRS cases.

HFRS Treatment

• Supportive management of fluid balance, renal function, and electrolytes through each clinical phase
• Dialysis may be required during the oliguric phase for severe acute kidney injury
• Intravenous ribavirin has shown some benefit for Hantaan and Dobrava virus HFRS when given early
• Careful fluid replacement during the diuretic phase to prevent dehydration

Prevention & Vaccines

• Rodent control: The primary prevention strategy. Seal gaps and holes in homes and outbuildings to prevent rodent entry. Store food in rodent-proof containers. Use snap traps in areas with rodent activity.
• Safe cleaning of rodent-contaminated areas: Ventilate the area for at least 30 minutes before entry; wear rubber gloves and N95 respirator; wet droppings with bleach solution before wiping; never sweep or vacuum dry droppings.
• Personal protective equipment: N95 or higher respirators, rubber gloves, and eye protection when entering potentially contaminated spaces (closed cabins, barns, sheds).
• Camping precautions: Avoid sleeping on bare ground in rodent-endemic areas; use tents with floors; store food properly; avoid disturbing rodent burrows or nests.
• Vaccines: Inactivated bivalent Hantaan/Seoul virus vaccines are approved and used in China and South Korea for high-risk populations. No vaccine is approved for Sin Nombre virus (HPS in North America) or Andes virus (South America). Several recombinant vaccine candidates are in development.

Global Impact

Hantavirus disease affects populations across multiple continents with distinct epidemiological patterns. HFRS is the more prevalent syndrome globally, with an estimated 200,000 cases per year. China accounts for approximately 70–90% of all HFRS cases reported worldwide — primarily caused by Hantaan and Seoul viruses. European HFRS (mainly Puumala virus carried by bank voles) causes periodic outbreaks in Scandinavia, Germany, France, and the Balkans, with tens of thousands of cases during peak years tied to rodent population cycles.

HPS, while less common numerically, carries a devastating case fatality rate of 35–38%. Since its recognition in 1993, HPS has been confirmed in 35 US states; Argentina and Chile have recorded hundreds of cases each. The Andes virus in South America is of particular concern because it is the only hantavirus documented to spread person-to-person — documented in family clusters and healthcare worker infections in Argentina and Chile.

Climate fluctuations (El Niño events) that increase rodent food availability lead to population explosions of reservoir rodents and subsequent hantavirus outbreaks in humans. The 1993 Four Corners outbreak followed an exceptionally wet winter that increased deer mouse populations. Similar patterns have been observed in South America and Europe. Climate change is expected to alter the geographic range of rodent populations and their associated hantavirus strains.

Country-Specific Information

USA (HPS): Since 1993, the CDC has recorded approximately 850 confirmed HPS cases in 35 states. The highest burden is in the Four Corners region (New Mexico, Colorado, Arizona, Utah) and throughout the western United States. Case fatality rate remains approximately 35–38%. The deer mouse (Peromyscus maniculatus) is the primary reservoir for Sin Nombre virus.

Argentina & Chile (Andes virus): South America's most important hantavirus is Andes virus, carried by the long-tailed pygmy rice rat. Argentina reports the most HPS cases in South America. Crucially, Andes virus can spread person-to-person — documented clusters in Patagonia involving family members and healthcare workers who provided close care to HPS patients. CFR in South American HPS is similar to North American cases.

China (HFRS): China dominates global HFRS epidemiology, reporting 20,000–100,000 cases annually — approximately 70–90% of global HFRS burden. Two viruses predominate: Hantaan virus (carried by the striped field mouse) causing severe HFRS in rural agricultural areas, and Seoul virus (carried by rats) causing milder urban HFRS. China has approved domestic bivalent vaccines and conducts mass vaccination campaigns in high-risk provinces.

Frequently Asked Questions

Sources & Citations

Related Diseases